Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
513.00    9.50 (1.89%)
Bid:
509.00
Ask:
509.50
Spread: 0.50 (0.098%)
Market Cap: £2.42b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

Board Changes

8 Apr 2025 07:00

RNS Number : 0089E
Pennon Group PLC
08 April 2025
 

The Board of Pennon Group Plc (the "Company") is pleased to announce that Andrea Blance has been appointed as a Non-Executive Director and Chair of the Remuneration Committee of the Company with effect from 8 April 2025. 

Andrea brings extensive risk and regulation expertise and is passionate about developing customer focused commercial strategies, following a long career in Financial Services. She is a Non-Executive Director and Risk Committee Chair at Aviva plc and an Advisory Board Member of The Mentoring Foundation.

Andrea spent her executive career at Legal & General Group plc where she held a range of senior leadership roles including Group Chief Risk Officer and Strategy & Marketing Director. More recently, Andrea has been Risk Committee Chair at Hargreaves Lansdown plc, Senior Independent Director and Remuneration Committee Chair of Vanquis Banking Group plc, Senior Independent Director and Audit Committee Chair of ReAssure plc, and Risk Committee Chair of Scottish Widows plc and Lloyds Banking Group Insurance.

Commenting on the appointment, David Sproul, Chair, said, "On behalf of the entire Board, I look forward to welcoming Andrea to Pennon. Her extensive regulatory experience and strong belief in the positive role that businesses should play delivering for customers and communities, and driving sustainable shareholder value, will be invaluable."

Andrea said, "I am absolutely delighted to have been appointed as Remuneration Chair of Pennon. I look forward to working with the Board and a brilliant team of valued colleagues as we look to deliver for customers and all stakeholders, with an enduring positive impact on the environment and society."

The Company confirms that there is no other information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to these appointments.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUBAKRVKUSRAR
Date   Source Headline
24th Dec 202011:14 amRNSHolding(s) in Company
22nd Dec 20205:15 pmRNSDirector/PDMR Shareholding
30th Nov 20201:41 pmRNSTotal Voting Rights
24th Nov 20207:00 amRNSPennon Half Year Results 2020/21
20th Nov 20202:40 pmRNSDirector/PDMR Shareholding
30th Oct 20204:02 pmRNSTotal Voting Rights
28th Oct 20202:44 pmRNSDirector/PDMR Shareholding
23rd Oct 20207:00 amRNSWaterShare+ Scheme Result of Share Offer
20th Oct 20203:53 pmRNSDirector/PDMR Shareholding
20th Oct 202011:00 amRNSHolding(s) in Company
14th Oct 20203:35 pmRNSHolding(s) in Company
1st Oct 202011:50 amRNSTotal Voting Rights
25th Sep 20207:00 amRNSTrading Statement
23rd Sep 20205:20 pmRNSHolding(s) in Company
22nd Sep 20204:02 pmRNSDirector/PDMR Shareholding
21st Sep 20204:54 pmRNSHolding(s) in Company
18th Sep 20201:05 pmRNSPublication of Prospectus – WaterShare+ Scheme
8th Sep 20203:50 pmRNSDirector/PDMR Shareholding
4th Sep 20202:19 pmRNSDirector/PDMR Shareholding
1st Sep 202010:49 amRNSTotal Voting Rights
21st Aug 20203:12 pmRNSDirector/PDMR Shareholding
4th Aug 202012:38 pmRNSDirector/PDMR Shareholding
3rd Aug 20202:10 pmRNSBlock listing Interim Review
3rd Aug 20202:05 pmRNSTotal Voting Rights
31st Jul 20202:02 pmRNSResult of AGM
21st Jul 20205:21 pmRNSDirector/PDMR Shareholding
15th Jul 202011:15 amRNSDirector/PDMR Shareholding
10th Jul 202010:22 amRNSAdditional Listing
8th Jul 20201:10 pmRNSViridor sale completion, Board changes and AGM
7th Jul 202010:58 amRNSAdditional Listing
3rd Jul 20209:31 amRNSPUBLICATION OF ANNUAL REPORT AND ACCOUNTS 2020
1st Jul 202011:11 amRNSTotal Voting Rights
23rd Jun 20202:33 pmRNSDirector/PDMR Shareholding
4th Jun 20207:00 amRNSPennon Full Year Results 2019/20
1st Jun 20201:28 pmRNSTotal Voting Rights
28th May 202012:26 pmRNSResult of Meeting
20th May 20205:14 pmRNSDirector/PDMR Shareholding
7th May 20201:52 pmRNSPublication of Circular and Notice of GM
6th May 20207:00 amRNSRedemption of £300m Capital Securities
1st May 202012:35 pmRNSTotal Voting Rights
24th Apr 20202:30 pmRNSHolding(s) in Company
22nd Apr 20201:36 pmRNSDirector/PDMR Shareholding
9th Apr 20205:19 pmRNSDirector/PDMR Shareholding
1st Apr 20205:17 pmRNSTotal Voting Rights
30th Mar 20207:00 amRNSFull Year 2019/20 Trading Statement
24th Mar 20201:20 pmRNSHolding(s) in Company
20th Mar 20204:54 pmRNSDirector/PDMR Shareholding
18th Mar 20203:06 pmRNSProposed Sale of Viridor for £4.2 billion to KKR
28th Feb 202012:26 pmRNSTotal Voting Rights
21st Feb 202010:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.